The Forgotten Pump - Waitlist & Post-Transplant Outcomes of Heart Transplant Recipients Supported by Heartware HVAD Before & After Device Recall
Purpose: In June 2021, the FDA issued a recall of the Heartware HVAD device prompting changes to the 2018 UNOS allocation policy. In July 2022, UNOS allowed patients with HVAD to be listed as Status 1,2, or 3 using the exception pathway and did not require hospitalization for higher status. What impact these changes had on waitlist and post-transplant outcomes for HVAD patients has yet to be reported.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: , A. Jawaid, R. Morlend, M. Thomas, N. Hendren, J. Weston, C. Heid, K. Ginder, E. Hardin, F. Araj, M. Farr, M. Peltz, L. Truby Source Type: research
More News: Cardiology | Heart | Heart Transplant | Lung Transplant | Transplant Surgery | Transplants